Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

Published:2019-02-18 Issue:5 Volume:9 Page:646-661
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Sen Triparna,Rodriguez B. Leticia,Chen Limo,Corte Carminia M. Della,Morikawa Naoto,Fujimoto Junya,Cristea Sandra,Nguyen Thuyen,Diao Lixia,Li Lerong,Fan Youhong,Yang Yongbin,Wang Jing,Glisson Bonnie S.,Wistuba Ignacio I.,Sage Julien^ORCID,Heymach John V.^ORCID,Gibbons Don L.,Byers Lauren A.

Funder

HHS | NIH | National Cancer InstituteHHS | NIH | National Cancer Institute (NCI)

Lung Cancer Research FoundationLung Cancer Research Foundation (LCRF)

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 610 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistance in Prostate Cancer;Current Medicinal Chemistry;2024-12

2. Recent advances in polysulfide-based prodrug nanomedicines for cancer therapy;Coordination Chemistry Reviews;2024-11

3. Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinoma;BMC Cancer;2024-09-12

4. Tetrandrine activates STING/TBK1/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer;Pharmacological Research;2024-09

5. Self-assembly of a ruthenium-based cGAS-STING photoactivator for carrier-free cancer immunotherapy;European Journal of Medicinal Chemistry;2024-09